Clearside Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CLSD Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Feb 25	BuyUS$13,800	Clay Thorp	Individual	15,000	US$0.92
01 Nov 24	BuyUS$36,500	Ngai Hang Chong	Individual	36,500	US$1.00
24 Jun 24	BuyUS$24,910	Ngai Hang Chong	Individual	23,500	US$1.06
15 May 24	BuyUS$10,235	Benjamin Yerxa	Individual	7,813	US$1.31

Insider Trading Volume

Insider Buying: CLSD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLSD?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	10,306,342	13.3%
Institutions	11,725,909	15.2%
General Public	55,247,035	71.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 27.11% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.52%	Bradford Whitmore	4,268,969	US$3.7m	-5.03%	no data
5.18%	Stephen Wiles	4,003,553	US$3.5m	0%	no data
3.63%	The Vanguard Group, Inc.	2,806,607	US$2.5m	-1.18%	no data
2.92%	Grace Brothers Management, LLC	2,254,542	US$2.0m	-4.07%	44.64%
2.5%	Carmignac Gestion SA	1,933,531	US$1.7m	0%	0.01%
1.14%	BlackRock, Inc.	877,647	US$766.9k	9.17%	no data
0.99%	Geode Capital Management, LLC	764,058	US$667.6k	4.47%	no data
0.93%	Renaissance Technologies LLC	721,789	US$630.7k	-3.1%	no data
0.52%	First Manhattan Co. LLC	405,668	US$354.5k	-39.1%	no data
0.5%	George Lasezkay	382,764	US$334.5k	0%	no data
0.48%	Charles Deignan	373,099	US$326.0k	10.6%	no data
0.34%	State Street Global Advisors, Inc.	265,263	US$231.8k	29.3%	no data
0.33%	Bridgeway Capital Management, LLC	255,000	US$222.8k	0%	no data
0.23%	Clay Thorp	176,141	US$153.9k	-7.85%	no data
0.22%	Richard Croarkin	169,736	US$148.3k	0%	no data
0.21%	Northern Trust Global Investments	165,499	US$144.6k	24%	no data
0.2%	Jeffrey Edwards	152,500	US$133.3k	0%	no data
0.19%	UBS Asset Management AG	145,118	US$126.8k	0%	no data
0.17%	Morgan Stanley, Investment Banking and Brokerage Investments	131,998	US$115.3k	1.38%	no data
0.17%	Assenagon Asset Management S.A.	131,913	US$115.3k	0%	no data
0.16%	Douglas W. Reed	127,011	US$111.0k	0%	no data
0.16%	John Crumpler	125,793	US$109.9k	0%	no data
0.14%	PNC Financial Services Group Inc., Banking Investments	108,244	US$94.6k	0.3%	no data
0.13%	CapFinancial Partners, LLC, Asset Management Arm	101,208	US$88.4k	9.14%	no data
0.13%	Anthony Gibney	100,000	US$87.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/01 09:11
End of Day Share Price	2025/04/30 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clearside Biomedical, Inc. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Daniil Gataulin	Chardan Capital Markets, LLC
Donald Ellis	Citizens JMP Securities, LLC
Jonathan Wolleben	Citizens JMP Securities, LLC